INSYS Therapeutics to Present at J.P. Morgan Healthcare Conference
PHOENIX, Jan. 03, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), announced today that Saeed Motahari, president and chief executive officer, and Andrew Long, chief financial officer, will present at the 36th annual J.P. Morgan Healthcare Conference as follows:
| Date: | Thursday, Jan. 11, 2018 | |||
| Time: | 7:30 a.m. Pacific Standard Time | |||
| Location: | San Francisco – Westin St. Francis Hotel |
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Investors section of company’s website at https://www.insysrx.com/, under Presentations & Events. The presentation slides will be available during the conference, accessible at the same webpage.
In addition to making a presentation, management will also provide an overview of the company’s business in one-on-one meetings with investors who are registered to attend the conference.
About INSYS INSYS Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients’ quality of life. Using proprietary spray technology and capabilities to develop pharmaceutical cannabinoids, INSYS is developing a pipeline of products intended to address unmet medical needs and the clinical shortcomings of existing commercial products.
| CONTACT: | Corporate Communications | Investor Relations |
| Joe McGrath | Jackie Marcus or Chris Hodges | |
| INSYS Therapeutics | Alpha IR Group | |
| 480-500-3101 | 312-445-2870 | |
| [email protected] | [email protected] |